Search Results

You are looking at 11 - 20 of 22 items for :

  • "oclacitinib" x
  • Refine by Access: All Content x
Clear All

extensive, viral papillomas in older dogs are often associated with immunosuppression, either iatrogenic (such as with cyclosporin, oclacitinib, glucocorticoid, or mycophenolate administration) or secondary to host immunodeficiencies. 4 , 6 – 12 Reported

Open access
in Journal of the American Veterinary Medical Association

. The patient was being treated for suspected atopic dermatitis with oclacitinib (0.6 mg/kg, PO, q 24 h) and cephalexin (32.6 mg/kg, PO, q 12 h) with minimal improvement. A CBC, biochemical panel, and measurements of thyroxine and free

Open access
in Journal of the American Veterinary Medical Association

-inflammatory course of prednisone and oclacitinib (1 mg/kg orally, per day) for suspected allergic dermatitis based on licking the right forelimb. Approximately 3 weeks later, the patient developed generalized seizures, which progressed to unyielding cluster seizures

Free access
in Journal of the American Veterinary Medical Association

/d, atropine 1% OS 2 times/d, hydrophilic carbomer gel OS 2 times/d, serum OS 4 times/d, cyclosporine 0.2% OS 2 times/d Oclacitinib 4 Ciprofloxacin 0.3% OS 4 times/d Moxifloxacin 0.5% OS 4 times/d 19 2 Healed with conjunctival graft 37 d

Full access
in Journal of the American Veterinary Medical Association
Author:

furoate), can effectively be used to treat common ear and eye conditions. Use of newer medications for atopy and allergic skin disease (eg, oclacitinib) make treatment for these conditions more successful, in part by reducing the need for a multimodal

Full access
in Journal of the American Veterinary Medical Association

and a second dog receiving famotidine and oclacitinib. Regurgitation episodes There was no significant ( P = 0.385) difference between number of regurgitation episodes per week at baseline (median, 6.5 episodes/wk; range, 1.5 to 19.5 episodes

Full access
in American Journal of Veterinary Research

, contrary to FDA-approved labeling, it is recommended that long-term use of oclacitinib be avoided because of an increase in the risk for adverse effects. Furthermore, several sections recommend the administration of fluralaner at 30- to 60-day intervals for

Full access
in Journal of the American Veterinary Medical Association

KR , Cosgrove SB , Stegemann MR . A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs . Vet Dermatol . 2015 ; 26 ( 1 ): 23-e8 . doi

Full access
in Journal of the American Veterinary Medical Association
Author:

long-term maintenance. Semi-broad (eg, oclacitinib)- or narrow (eg, lokivetmab and antihistamines)- spectrum agents have limited efficacy in otitis. Table 8 Treatment options for chronic pathological inflammatory changes. Changes

Full access
in Journal of the American Veterinary Medical Association

control atopic dermatitis. Concurrent medications included macrocyclic lactones (n = 15), antimicrobials (8), antihistamines (6), oclacitinib l (4), carprofen (4), caninized monoclonal antibody against interleukin-31 m (3), glucocorticoid medications (2

Full access
in Journal of the American Veterinary Medical Association